Impact of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on door-to-needle time.

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

The European Cooperative Acute Stroke Study (ECASS) III extended the thrombolysis time window for patients with stroke from 3 to 4.5 hours after symptom onset. We investigated the effect of the extended thrombolysis time window on the proportion of recombinant tissue-type plasminogen activator-treated stroke patients and on the time of treatment initiation after hospital arrival.

Related collections

Author and article information

Journal

Journal ID (iso-abbrev): Stroke

Title: Stroke

Publisher: Ovid Technologies (Wolters Kluwer Health)

ISSN (Electronic): 1524-4628

ISSN (Print): 0039-2499

Publication date (Electronic): Oct 2011

Volume: 42

Issue: 10

Affiliations

[1 ] Department of Neurology, Institute of Epidemiology and Social Medicine, University of Münster, Domagkstrasse 3, Münster, Germany.

Article

Publisher Item ID: STROKEAHA.111.616565

DOI: 10.1161/STROKEAHA.111.616565

PubMed ID: 21852612

SO-VID: 4779a7a1-efc5-49e4-bfce-62cfddaaf725

History

Data availability:

Comments

Comment on this article

scite_

Cited by 10

See all cited by

- Version 1